Cacace Angela M sold $20K of ARVN
Cacace Angela M (Chief Scientific Officer) sold 2,576 shares of ARVINAS, INC. (ARVN) at $7.60 on 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing documents an officer’s scheduled open-market sale; it does not include guidance, trial results, contracts, or enforcement actions.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 structure limits fundamental interpretation.
What to watch
Insider sales can be misread; traders should check whether there are concurrent buys, option exercises, or other filings around the same period before inferring direction.
Background
The article is an SEC Form 4 insider transaction disclosure for ARVINAS, Inc.
Ticker impact
ARVINAS CSO Angela M. Cacace sold 2,576 shares in an open-market transaction at $7.5950 on 2026-06-17 under a 10b5-1 plan.
Low likelihood of a sustained price move from this filing alone; any impact would be short-lived sentiment noise.
The disclosure is an insider open-market sale, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operational, financial, or regulatory information.
Market effects
No clear sector read-through from a single routine 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerARVINAS, INC.
Company whose insider transaction is disclosed on Form 4.
- insiderAngela M. Cacace
Chief Scientific Officer who sold shares under a 10b5-1 plan.
